Provided by Tiger Trade Technology Pte. Ltd.

KALA BIO

0.5668
+0.01011.81%
Volume:305.14K
Turnover:174.21K
Market Cap:10.96M
PE:-0.01
High:0.6007
Open:0.5600
Low:0.5504
Close:0.5567
52wk High:1,030.00
52wk Low:0.4901
Shares:19.34M
Float Shares:18.59M
Volume Ratio:0.77
T/O Rate:1.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-72.4536
EPS(LYR):-165.5565
ROE:-345.32%
ROA:-65.43%
PB:1.21
PE(LYR):0.00

Loading ...

KALA BIO Updates Annual Meeting and Proposal Deadlines

TIPRANKS
·
Yesterday

Kala Bio Announces Next Annual Shareholder Meeting

Reuters
·
Yesterday

KALA BIO - Agreement Includes Right of First Refusal for Kala on Virotek Ophthalmology Products

THOMSON REUTERS
·
Sep 03

KALA BIO - Companies Agree to Profit-Sharing Structure Effective After Virotek Recovers Program Costs

THOMSON REUTERS
·
Sep 03

KALA BIO - to be Exclusive U.S. Distributor for Virotek Ophthalmology Genetic Testing for One Year

THOMSON REUTERS
·
Sep 03

KALA BIO and Virotek Finalize Definitive Agreement Establishing Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program

THOMSON REUTERS
·
Sep 03

Kala Bio Signs LOI for Exclusive US Distribution of Virotek Ophthalmology Genetic Tests

Reuters
·
Sep 01

KALA BIO and Virotek Announce Letter of Intent to Establish an Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program

THOMSON REUTERS
·
Sep 01

NASDAQ Trade Halt Volatility Trading Pause at 09:38 Am

Reuters
·
Aug 28

Kala Bio Faces NASDAQ Delisting After Stock Trades Below $1 for 30 Days

Reuters
·
Aug 28

Kala Bio Q2 EPS $(21.32) Up From $(85.64) YoY, Sales $0.00, Same YoY

Benzinga Earnings
·
Aug 20

Kala Bio Q2 Net Loss Narrows to $1.58 Million from Year-Ago $11.16 Million

Reuters
·
Aug 20

KALA BIO Announces Brief Delay in Quarterly Filing

TIPRANKS
·
Aug 15

Kala Bio Delays Q2 Form 10-Q Filing, Cites Added Time for Liquidity Disclosure

Reuters
·
Aug 14

Kala Bio Files ATM Offering of up to $250 Million in Common Stock - SEC Filing

Reuters
·
Jul 23

KALA BIO Files Atm Offering of up to $250.00 Mln in Common Stock - SEC Filing

THOMSON REUTERS
·
Jul 23

Kala Bio Q1 EPS $(0.14) Beats $(0.30) Estimate

Benzinga Earnings
·
May 16

Kala Bio Q1 FY26 net loss narrows to $1.62 million

Reuters
·
May 16

Kala Bio falls -21.7%

TIPRANKS
·
May 13

KALA BIO Inc - May Offer up to $350 Mln in Securities - SEC Filing

THOMSON REUTERS
·
May 08